Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment

N Leonard, AE Bishop, JM Polak and IC Talbot
Department of Histopathology, St Mark's Hospital, London, UK.

AIM: To examine the effect of corticosteroid treatment on the expression of inducible nitric oxide synthase (iNOS) in the colon of patients with inflammatory bowel disease. METHODS: Four groups of patients were studied: (1) ulcerative colitis treated with high dose corticosteroids (six patients, 10 blocks); (2) ulcerative colitis patients who had never received corticosteroids (10 patients, 16 blocks); (3) Crohn's disease treated with high dose corticosteroids (12 patients, 24 blocks); (4) Non-inflammatory, non-neoplastic controls (four patients, six blocks). Full thickness paraffin sections of colons removed at surgery were immunostained with an antibody raised against the C terminal end of iNOS. Sections were assessed semiquantitatively for the presence and degree of inflammation and immunoreactivity for nitric oxide synthase. RESULTS: Cases of ulcerative colitis and Crohn's disease with active inflammation showed strong staining for nitric oxide synthase. The staining was diffuse in ulcerative colitis and patchy in Crohn's disease, in accordance with the distribution of active inflammation. Staining was seen in epithelial cells and was most intense near areas of inflammation such as crypt abscesses. Non- inflamed epithelium showed no immunoreactivity. Treatment with corticosteroids made no difference to the amount of nitric oxide synthase. CONCLUSIONS: Expression of nitric oxide synthase is increased in both ulcerative colitis and Crohn's disease and appears to be unaffected by treatment with corticosteroids. Disease severity necessitated surgery in all the cases included in this study, regardless of whether or not the patients had received long term corticosteroid treatment. It seems therefore that a high level of iNOS expression and, presumably, production of nitric oxide characterise cases which are refractory to clinical treatment; this suggests that specific inhibition of the enzyme may be a useful therapeutic adjunct.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Shiroshita-Takeshita, A., Brundel, B. J.J.M., Lavoie, J., Nattel, S. (2006). Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs. Cardiovasc Res 69: 865-875 [Abstract] [Full Text]  
• Cao, W., Fiocchi, C., Pricolo, V. E. (2005). Production of IL-1{beta}, hydrogen peroxide, and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis. Am. J. Physiol. Cell Physiol. 289: C1408-C1416 [Abstract] [Full Text]  
• Linehan, J. D., Kolios, G., Valatas, V., Robertson, D. A. F., Westwick, J. (2005). Effect of corticosteroids on nitric oxide production in inflammatory bowel disease: are leukocytes the site of action?. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G261-G267 [Abstract] [Full Text]  
• Tedeschi, E., Menegazzi, M., Yao, Y., Suzuki, H., Forstermann, U., Kleinert, H. (2004). Green Tea Inhibits Human Inducible Nitric-Oxide Synthase Expression by Down-Regulating Signal Transducer and Activator of Transcription-1{alpha} Activation. Mol. Pharmacol. 65: 111-120 [Abstract] [Full Text]  
• Tedeschi, E., Menegazzi, M., Margotto, D., Suzuki, H., Forstermann, U., Kleinert, H. (2003). Anti-Inflammatory Actions of St. John's Wort: Inhibition of Human Inducible Nitric-Oxide Synthase Expression by Down-Regulating Signal Transducer and Activator of Transcription-1{alpha} (STAT-1{alpha}) Activation. J. Pharmacol. Exp. Ther. 307: 254-261 [Abstract] [Full Text]  
• van Deventer, S J H (2002). Small therapeutic molecules for the treatment of inflammatory bowel disease. Gut 50: iii47-53 [Abstract] [Full Text]  
• Donnelly, L. E., Barnes, P. J. (2002). Expression and Regulation of Inducible Nitric Oxide Synthase from Human Primary Airway Epithelial Cells. Am. J. Respir. Cell Mol. Bio. 26: 144-151 [Abstract] [Full Text]  
• Roberts, P J, Riley, G P, Morgan, K, Miller, R, Hunter, J O, Middleton, S J (2001). The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. J. Clin. Pathol. 54: 293-297 [Abstract] [Full Text]  
• Hsieh, T.-c., Juan, G., Darzynkiewicz, Z., Wu, J. M. (1999). Resveratrol Increases Nitric Oxide Synthase, Induces Accumulation of p53 and p21WAF1/CIP1, and Suppresses Cultured Bovine Pulmonary Artery EndothelialCell Proliferation by Perturbing Progression through S and G2. Cancer Res. 59: 2596-2601 [Abstract] [Full Text]